Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction.
about
Influence of Acute and Chronic Exercise on Glucose UptakeEffects of walking on low-grade inflammation and their implications for Type 2 DiabetesInterleukin-6 myokine signaling in skeletal muscle: a double-edged sword?Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and HepatokinesHeat stress, gastrointestinal permeability and interleukin-6 signaling - Implications for exercise performance and fatigueMuscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injurySkeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exerciseHormone replacement therapy and physical function in healthy older men. Time to talk hormones?Interleukin-6 increases the expression and activity of insulin-degrading enzyme.Human IL6 enhances leptin action in mice.Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 daysLong-lasting effect of obesity on skeletal muscle transcriptome.IL-6 in diabetes and cardiovascular complications.FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exerciseMuscle as a secretory organ.Effect of different training mode on Interleukin-6 (IL-6) and C-reactive protein (CRP) in type 2 diabetes mellitus (T2DM) patients.Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse.Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines.Effect of Nigella sativa on immune response in treadmill exercised ratMetabonomics-based omics study and atherosclerosis.Vitamin D receptor protein is associated with interleukin-6 in human skeletal muscleInterleukin-6 and insulin sensitivity: friend or foe?Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humansRole of osteoglycin in the linkage between muscle and bone.Physical activity and modulation of systemic low-level inflammation.Altered response of skeletal muscle to IL-6 in type 2 diabetic patients.An overview of the contribution of fatness and fitness factors, and the role of exercise, in the formation of health status for individuals who are overweight.Muscle-to-organ cross talk mediated by myokinesThe role of interleukin-6 in insulin resistance, body fat distribution and energy balance.Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to ExerciseFatigue and illness in athletes.Four grams of glucose.Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged menCardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography.The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK.Defining the interorgan communication network: systemic coordination of organismal cellular processes under homeostasis and localized stress.Getting the message across: mechanisms of physiological cross talk by adipose tissue.Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach.Genomics and genetics in the biology of adaptation to exercise.Evaluation of immune response after moderate and overtraining exercise in wistar rat.
P2860
Q26748964-B51B85E3-8AAF-446F-A6EA-F21675AA28ACQ26769053-8310E3EA-7422-49F1-8C07-0152D4E97C0BQ26866208-6D1ED011-1F39-46BE-8EB7-0A1F26D65054Q28066564-7B0A54FB-FC63-472D-B688-815DBD6679E3Q28077718-A0D63B97-E55B-4D73-9962-14BD6062800CQ28238431-BE4A91BF-B236-4B37-BAEB-C3329356F1EBQ28566793-35074900-C2BA-4E62-9873-450BE5FE9605Q33569163-78AF4876-E16A-430F-B36D-B4F1BCFE4719Q33587718-192DA61E-E772-4C5F-9949-47A365188A60Q33628094-3C7F6E3C-1D3C-496E-9659-04C400F35F2EQ33656668-EEC42BA0-D60C-4155-818A-06BA8F0E91C9Q33729970-1F0A7F70-581D-40E9-8E53-538DD018A34AQ34025142-96BE49C1-1B14-48C2-88E8-584EC285772FQ34302332-0E25F5E6-4C37-434B-8D47-532FF14A5147Q34360586-030E2271-252D-40ED-91C1-2FEDD1AD2B43Q35064819-46122F30-F489-4E35-BE73-FE5B13B784E4Q35195052-757C3693-9ADF-4F41-82E8-9FB43C02D080Q35208163-CC94B477-E556-4898-BA29-744747AC67B7Q35404245-6C7F4504-7524-48CD-8AEB-7CF863653B9EQ35568736-5D068567-28EC-46A3-BC85-F325718CE72FQ35661120-1D78CB34-A0DF-49EF-B913-0CDB2F6C7848Q35829806-885B20F3-C2AB-49A2-A1D6-D0B9E2111176Q35838041-AEC319AF-BC17-4BA4-BB9E-CD7C61903130Q35874317-7CAEC8F6-FB4D-491D-909A-0A8F45D15444Q36201980-27BA0C54-ECBB-43BA-A21E-A4981B90971FQ36560588-306087C4-BDDF-4B97-9F20-0B70ED0E9591Q36697884-D2BC692A-132F-49EA-80DD-DCBD5CD53118Q36719110-FAC97656-A9AB-4BDE-9CAD-037E366B5F53Q36979956-058749ED-4A19-4706-B256-F135139E6573Q37012238-DC9DE6A4-FEA2-4838-87CB-5DA82D787960Q37020246-E4B26C20-FE75-4913-8BE2-BF5A2E7AC105Q37086438-9D0D1C8D-F782-4076-8BB3-E532009E1720Q37170868-D916084F-7A9A-46D7-8CE8-79B2EF9EDF55Q37180152-80046966-91D1-40B7-8FE0-81CC0C2E22E1Q37309992-2F34C4C9-B90D-4E91-94FF-89337069454EQ37321819-B1591C0B-4D84-4EB5-A80F-5EE040617164Q37405747-F4EB2AC7-3809-41D8-82DE-0063168C3615Q37578545-3DEC319B-7E46-4A63-A886-A0DD7063E508Q37609488-52EF1CAF-ACBD-42A5-9B67-7909E2072A5FQ37610557-2B197F96-48EA-4062-B5D3-FA2BC15DFCBB
P2860
Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Interleukin-6 is a novel facto ...... g skeletal muscle contraction.
@en
Interleukin-6 is a novel facto ...... g skeletal muscle contraction.
@nl
type
label
Interleukin-6 is a novel facto ...... g skeletal muscle contraction.
@en
Interleukin-6 is a novel facto ...... g skeletal muscle contraction.
@nl
prefLabel
Interleukin-6 is a novel facto ...... g skeletal muscle contraction.
@en
Interleukin-6 is a novel facto ...... g skeletal muscle contraction.
@nl
P50
P1433
P1476
Interleukin-6 is a novel facto ...... g skeletal muscle contraction.
@en
P2093
Mark A Febbraio
Natalie Hiscock
P304
P356
10.2337/DIABETES.53.7.1643
P407
P577
2004-07-01T00:00:00Z